The effect of vaginal hyoscine butyl bromide on cervical ripening before hysteroscopy

Phase 3

Recruiting

• Conditions: Condition 1: Uterine polyp. Condition 2: endometrial hyperplasia. Condition 3: Submucousal fibroid. Condition 4: Abnormal uterine bleeding. Condition 5: Noninflammatory disorder of uterus, unspecified. Condition 6: Patients who are candidates for hysteroscopy.; Polyp of corpus uteri; Endometrial hyperplasia; Submucous leiomyoma of uterus; Abnormal uterine and vaginal bleeding, unspecified; Noninflammatory disorder of uterus, unspecified; Inflammatory disease of uterus, unspecified; N84.0; N85.0; D25.0

• Registration Number: IRCT20190929044920N1
• Lead Sponsor: Zahedan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 17 December 2019

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 150

Inclusion Criteria

Women candidates for hysteroscopy
Age between 18-65 years

Exclusion Criteria

Dissatisfaction with continuing treatment process
Sensitivity to the drugs used
Asthma
Glaucoma
cardiovascular disease
Taking antihypertensive drugs
Sensitivity to prostaglandins

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Frequency of Dilator Hagar Crossings No. 5. Timepoint: After complete anesthesia. Method of measurement: Hagar Number Five Crossing.;Duration of operation time. Timepoint: Duration of operation. Method of measurement: Stopwatch.;Side effects. Timepoint: From medication to discharge. Method of measurement: Complete patient examination.;Severity of pain. Timepoint: During surgery and half an hour after surgery. Method of measurement: The visual acuity scale (VAS) zero to ten.;Cervical dilatation rate. Timepoint: Check in operation. Method of measurement: Based on measurements by Hegar and hysteroscopes.

Secondary Outcome Measures

Name	Time	Method
Duration of operation time. Timepoint: Duration of operation. Method of measurement: Stopwatch.;Side effects. Timepoint: From medication to discharge. Method of measurement: Complete patient examination.;Severity of pain. Timepoint: During surgery and half an hour after surgery. Method of measurement: The visual acuity scale (VAS) zero to ten.;Cervical dilatation rate. Timepoint: Check in operation. Method of measurement: Based on measurements by Hegar and hysteroscopes.